| アイテムタイプ |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2024-03-06 |
| タイトル |
|
|
タイトル |
Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder. |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Satoshi Kasahara
Miwako Takahashi
Taito Morita
Ko Matsudaira
Naoko Sato
Toshimitsu Momose
Shin-Ichi Niwa
Kanji Uchida
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
It is known that patients reporting chronic pain often experience trauma or post-traumatic stress disorder (PTSD) and tend to be more difficult to treat. Attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, is frequently associated with chronic pain. Furthermore, patients diagnosed with ADHD are more likely to encounter trauma and develop PTSD because of their inattentive and impulsive tendencies. There are reports stating that atomoxetine (ATX), a selective noradrenaline reuptake inhibitor for ADHD, is effective in patients diagnosed with PTSD and ADHD. However, there have been no reports on cases of comorbid PTSD and ADHD with chronic pain, and ATX's potential in improving chronic pain coexisting PTSD. Furthermore, no reports have evaluated patient cerebral blood flow in conjunction with the course of treatment with ATX for chronic pain. |
| 書誌情報 |
Frontiers in psychiatry
巻 7,
号 14,
p. 1221694,
発行日 2023-09
|
| PubMed番号 |
|
|
|
識別子タイプ |
PMID |
|
|
関連識別子 |
37608999 |
| DOI |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.3389/fpsyt.2023.1221694 |
